# Screening to Prophylax Against Clostridium Difficile Infection -

> **NCT02996487** · PHASE4 · COMPLETED · sponsor: **Corewell Health East** · enrollment: 1294 (actual)

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** Vancomycin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02996487
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-19
- **Primary completion:** 2023-06-28
- **Final completion:** 2023-06-28
- **Target enrollment:** 1294 (ACTUAL)
- **Last updated:** 2024-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02996487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02996487, "Screening to Prophylax Against Clostridium Difficile Infection -". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02996487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*